newsranbaxy

Ranbaxy denied Lipitor rehearing MUMBAI: In a major blow to Delhi-based pharma major Ranbaxy, a US appeals court has denied a rehearing of its patent challenge to Pfizer's cholesterol- lowering drug, Lipitor. Lipitor is the world's best-selling prescription drug, raking in more than $12 billion...